<DOC>
	<DOCNO>NCT02222116</DOCNO>
	<brief_summary>The objective demonstrate Flow Area within block coronary vessel assess OCT great MGuard Prime stent compare non-mesh control stent ( BMS/DES ) subject undergoing primary PCI ST-segment elevation MI . The study hypothesis end procedure flow area great MGuard Prime compare stenting non-mesh DES BMS .</brief_summary>
	<brief_title>OCT Study MGuard Prime Stent Patients With Heart Attacks</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Subject &gt; 18 year age . Subject experience clinical symptom consistent acute myocardial infarction ( AMI ) &gt; 30 minute ≤12 hour duration . STsegment elevation ≥1 mm per lead ≥2 contiguous lead present least one ECG prior consent . Subject agree require followup procedure visit . Subject provide write , informed consent . The target lesion single de novo lesion native coronary artery . Based coronary anatomy , PCI indicate culprit lesion anticipate use stenting . TIMI flow 0/1 present baseline TIMI flow 2/3 present prior randomization . The reference vessel diameter ( RVD ) infarct lesion 2.754.0 mm visual assessment , assess TIMI 2/3 flow restore . The entire lesion length require treatment ≤33 mm visual assessment , assess TIMI 2/3 flow restore . Currently enrol another investigational device drug trial reach primary endpoint clinically interfere current study endpoint . A previous coronary interventional procedure kind within 30 day Female patient childbearing potential . Subject undergoing cardiopulmonary resuscitation ( patient cardiopulmonary resuscitation successfully perform normal mental status achieve , may enrol ) . Cardiogenic shock ( SBP &lt; 80 mmHg &gt; 30 minute , require IV pressor intraaortic balloon bump ( IABP ) hemodynamic support device hypotension ) . Prior administration thrombolytic therapy current admission Concurrent medical condition life expectancy le 12 month . History cerebrovascular accident transient ischemic attack within last 6 month , permanent neurologic deficit Prior intracranial bleed time , know intracranial pathology ( e.g . tumor , arteriovenous malformation , aneurysm ) . Active recent major bleed within 6 month . History bleed diathesis coagulopathy inability accept blood transfusion . Known hypersensitivity contraindication ) aspirin ; ii ) heparin bivalirudin ; iii ) clopidogrel , prasugrel ticagrelor ; iv ) cobalt nickel ; v ) contrast medium , adequately premedicated ( prior anaphylaxis , however , absolute contraindication enrollment ) . Known calculated creatinine clearance &lt; 30 mL/min , hemoglobin &lt; 10 g/dL platelet count &lt; 150,000 present admission within 7 day prior index procedure , available . NOTE : Baseline labs available consent patient . If laboratory result become available randomization , meet inclusion exclusion criterion , patient deregistered study . Surgery plan reason necessitate discontinuation dual antiplatelet therapy ( aspirin ADP antagonist ) within 6 month . Rheolytic thrombectomy , PTCA balloon diameter &gt; 2.0 mm , device ( guide wire simple manual aspiration ) require restore TIMI 2/3 flow infarct vessel . Unprotected leave main stenosis ≥50 % plan leave main intervention . Any nonstudy lesion infarct artery visually estimate diameter stenosis ≥50 % reference vessel diameter ≥2.0 mm require treatment index procedure . Multivessel multilesion intervention require index procedure . Excessive tortuosity , calcification diffuse distal disease present either proximal , distal target lesion make unlikely OCT catheter stent able reach deploy across target lesion full expansion . Target lesion bifurcation side branch ≥2.0 mm diameter . Target lesion site within vessel previously implant stent . Target lesion within bypass graft conduit , reach passing study stent bypass graft conduit . Aortic dissection mechanical complication STEMI ( papillary muscle rupture , ventricular septal defect free wall rupture without pseudoaneurysm ) identify left ventriculography modality ( echocardiography , MRI , CT , physical exam ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>STEMI</keyword>
	<keyword>BMS</keyword>
	<keyword>DES</keyword>
	<keyword>mesh</keyword>
</DOC>